Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Status Active, not recruiting

Clinical Trial Summary

The objective of the proposed study is to evaluate the efficacy of the Enhanced Milieu Teaching-Sentence Focus (EMT-SF) intervention, implemented by caregivers and interventionists, relative to a control condition enrolling 108 30-month-old children and their caregivers. The central hypothesis is that intervention will result in better overall child language skills at 49 months of age.

Clinical Trial Description

A multi-site, phase 2, randomized clinical trial will be used to determine whether communication support strategies are effective for improving language outcomes in children with emergent developmental language disorder. At study entry, 108 children with emergent developmental language disorder (DLD) at 30 months of age will be randomly assigned 1:1 to either the EMT-SF treatment condition or a Business as Usual (BAU) control group. The control group is necessary to determine the efficacy of the EMT-SF intervention. The EMT-SF group is necessary to evaluate the effects of systematically teaching caregivers to use these strategies. Because all children in the study have language delays that will make them eligible to receive the early intervention services through the state early intervention program, children in both experimental conditions will receive state-provided community-based intervention according to their Individualized Family Service Plan - the current standard of care or from private speech language therapy providers. Children in the EMT-SF condition will receive an additional 18 months of interventionist plus caregiver-implemented intervention sessions. Children in both groups will be assessed at the start of the study and every 3 months until the child is 49 months old. The goal is to enroll all children at 30 months of age and provide a minimum of 60 of the planned 66 sessions of intervention to each child in the treatment condition; however, variability in age at study entry (e.g., 30 months), intervention dosage, and number of assessment data points will be addressed in the statistical analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03782493
Study type	Interventional
Source	Northwestern University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	April 4, 2019
Completion date	July 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05242575` - The Influence of Immersive Virtual Field Trips on Academic Vocabulary	N/A
Enrolling by invitation	`NCT04508699` - Semantic Learning Deficits in School Age Children With Developmental Language Disorder	N/A
Recruiting	`NCT06026124` - Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading	N/A
Recruiting	`NCT05901493` - Category Learning Retention in Adults With and Without Developmental Language Disorder	N/A
Not yet recruiting	`NCT05988190` - Contextual Word Learning in Children With Developmental Language Disorder	N/A
Recruiting	`NCT05268341` - Neuroimaging Reveals Treatment-related Changes in DLD	N/A
Active, not recruiting	`NCT05325333` - Retrieval-Based Word Learning in Developmental Language Disorder	N/A
Completed	`NCT06001866` - Retrieval-Based Word Learning in Developmental Language Disorder: Verb Learning	N/A
Recruiting	`NCT05953077` - The Effect of Prior Learning on Treatment of Morpheme Errors	N/A
Recruiting	`NCT05678634` - Optimizing Feedback-based Learning in Children With Developmental Language Disorder	N/A
Recruiting	`NCT06156865` - Using Neuroimaging and Behavioral Assessments to Understand Late Talking	N/A
Recruiting	`NCT05767242` - Early Neurophysiological Markers of Language Impairments
Recruiting	`NCT04902508` - Evaluation of an Explicit Approach	N/A
Terminated	`NCT05127863` - Efficacy of a Pragmatic Intervention to Improve Adaptation to Context and Interlocutor	N/A
Recruiting	`NCT06085300` - The Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes of Bilingual Children With Developmental Language Disorder	N/A
Recruiting	`NCT04558541` - A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production	N/A
Recruiting	`NCT04996472` - A Framework For Linking Sequential Pattern Rules in DLD: Perception in Adults	N/A
Recruiting	`NCT04531514` - A Framework For Linking Sequential Pattern Rules in DLD: Perception in Toddlers	N/A
Completed	`NCT05295472` - Reading Intervention to Children With Developmental Language Disorder	N/A
Recruiting	`NCT05445687` - Rehabilitation of Narrative Language in Children With Hearing Impairment and Developmental Language Disorder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.